Search results
To provide recommendations for the management of juvenile idiopathic arthritis (JIA) with a focus on nonpharmacologic therapies, medication monitoring, immunizations, and imaging, irrespective of JIA phenotype.
17 gru 2018 · Hyperextensibility. One common diagnosis in children who present with joint pain but a normal physical examination is hyperextensibility arthralgia, said Dr. Miller. Often, these patients have low-titer, positive antinuclear antibodies (ANA) for unknown reasons.
To develop treatment recommendations for children with juvenile idiopathic arthritis manifesting as non- systemic polyarthritis, sacroiliitis, or enthesitis. Methods. The Patient/Population, Intervention, Comparison, and Outcomes (PICO) questions were developed and refined by members of the guideline development teams.
This clinical practice guideline complements the 2019 ACR JIA and uveitis guidelines, on polyarthritis, sacroiliitis, enthesitis and uveitis, and a concurrent 2021 guideline on oligoarthritis, temporomandibular arthritis and systemic JIA. It serves as a tool to support clinicians, patients and caregivers in decision-making.
5 maj 2022 · The new ACR guideline for the treatment of juvenile idiopathic arthritis provides an update on several important topics, including management of oligoarthritis, temporomandibular joint...
16 sty 2023 · The most common presentation of musculoskeletal complaints is joint pain and soft tissue pain (65%), and the most common cause of all ages of children is trauma (45%). [24] Toxicity and Adverse Effect Management
12 lip 2024 · Juvenile idiopathic arthritis (JIA) describes a group of chronic paediatric inflammatory arthritides. There are several subtypes, including oligoarticular, polyarticular, and systemic onset. Affects 1 in 1000 children and can present at any age. Diagnosis is made clinically.
